Early Feasibility Study to Assess the Safety and Effectiveness of the OnePoint Dialysis CannulaTM as a Single-Site Vascular Access Device for Hemodialysis Procedures
NCT: NCT07599085 · NOT_YET_RECRUITING
広告
NCT識別子NCT07599085
ステータスNOT_YET_RECRUITING
開始日2026-08-01
SponsorEvolve Medicus, Inc. (INDUSTRY)
First posted
Last updated
概要
This is an early feasibility, pre-market, prospective, interventional, single-arm, non-randomized / open-label study intended to support a future pivotal IDE study for eventual FDA clearance of the study device based on the safety and efficacy of the device in cannulating arteriovenous fistulas (AVFs) for hemodialysis procedures.
公式ソース
ClinicalTrials.govで見る →データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。